Trademark: 78355965
Word
EE
Status
Dead
Status Code
606
Status Date
Monday, August 10, 2009
Serial Number
78355965
Mark Type
5000
Filing Date
Thursday, January 22, 2004
Published for Opposition
Tuesday, April 18, 2006
Abandoned Date
Monday, August 10, 2009

Trademark Owner History
EPIGENESIS PHARMACEUTICALS LLC - Owner At Publication
EPIGENESIS Pharmaceuticals, Inc. - Original Applicant

Classifications
5 Medical diagnostic and therapeutic preparations for clinical use, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold as a kit, namely inhalers; medical preparations namely nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
Color is not claimed as a feature of the mark.
The mark consists of stylized letter "E" connected to another transposed stylized letter "E" in a top to bottom alignment.

Trademark Events
Aug 10, 2009
Abandonment Notice Mailed - No Use Statement Filed
Aug 10, 2009
Abandonment - No Use Statement Filed
Jan 6, 2009
Extension 5 Granted
Jan 6, 2009
Extension 5 Filed
Jan 6, 2009
Teas Extension Received
Jul 1, 2008
Extension 4 Granted
Jul 1, 2008
Extension 4 Filed
Jul 1, 2008
Teas Extension Received
Jan 7, 2008
Extension 3 Granted
Jan 7, 2008
Extension 3 Filed
Jan 7, 2008
Teas Extension Received
Sep 9, 2007
Extension 2 Granted
Jul 3, 2007
Extension 2 Filed
Jul 3, 2007
Teas Extension Received
Mar 13, 2007
Extension 1 Granted
Jan 5, 2007
Extension 1 Filed
Jan 5, 2007
Teas Extension Received
Jul 11, 2006
Noa Mailed - Sou Required From Applicant
Apr 18, 2006
Published For Opposition
Mar 29, 2006
Notice Of Publication
Mar 3, 2006
Law Office Publication Review Completed
Feb 24, 2006
Assigned To Lie
Feb 22, 2006
Approved For Pub - Principal Register
Feb 22, 2006
Teas/Email Correspondence Entered
Feb 14, 2006
Correspondence Received In Law Office
Feb 14, 2006
Teas Response To Office Action Received
Sep 6, 2005
Non-Final Action E-Mailed
Sep 6, 2005
Non-Final Action Written
Sep 2, 2005
Previous Allowance Count Withdrawn
Aug 15, 2005
Withdrawn Before Publication
Jul 26, 2005
Law Office Publication Review Completed
Jul 22, 2005
Assigned To Lie
Jul 21, 2005
Approved For Pub - Principal Register
Jul 20, 2005
Teas/Email Correspondence Entered
Jul 11, 2005
Correspondence Received In Law Office
Jul 11, 2005
Teas Response To Office Action Received
Mar 9, 2005
Non-Final Action E-Mailed
Mar 9, 2005
Non-Final Action Written
Mar 1, 2005
Amendment From Applicant Entered
Jan 31, 2005
Correspondence Received In Law Office
Jan 31, 2005
Paper Received
Oct 5, 2004
Teas Change Of Correspondence Received
Aug 21, 2004
Non-Final Action E-Mailed
Aug 12, 2004
Assigned To Examiner
Jul 20, 2004
Teas Voluntary Amendment Received
Jul 16, 2004
Paper Received
Feb 2, 2004
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24